HKSE - Delayed Quote HKD
CONSUN PHARMA (1681.HK)
9.540
-0.170
(-1.75%)
As of 3:23:43 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,967,235
2,967,235
2,590,115
2,339,650
2,044,660
Cost of Revenue
725,133
725,133
668,437
576,738
517,324
Gross Profit
2,242,102
2,242,102
1,921,678
1,762,912
1,527,336
Operating Expense
1,279,333
1,279,333
1,111,644
1,043,455
875,024
Operating Income
962,769
962,769
810,034
719,457
652,312
Net Non Operating Interest Income Expense
63,413
63,413
47,653
41,481
26,343
Pretax Income
1,020,106
1,020,106
863,703
746,393
695,861
Tax Provision
102,732
102,732
77,149
62,696
108,744
Net Income Common Stockholders
910,458
910,458
784,534
682,907
590,172
Diluted NI Available to Com Stockholders
910,458
910,458
784,534
682,907
590,172
Basic EPS
1.05
1.11
0.99
0.86
0.74
Diluted EPS
1.04
1.09
0.98
0.86
0.73
Basic Average Shares
797,056.500
821,098
790,908
790,627
801,581
Diluted Average Shares
806,308
832,109
799,168
791,997
804,702
Total Operating Income as Reported
1,045,060
1,045,060
884,967
757,326
708,766
Total Expenses
2,004,466
2,004,466
1,780,081
1,620,193
1,392,348
Net Income from Continuing & Discontinued Operation
910,458
910,458
784,534
682,907
590,172
Normalized Income
902,876.962
902,876.962
773,833.551
684,022.688
591,851.560
Interest Income
88,301
88,301
68,917
52,414
39,248
Interest Expense
24,888
24,888
21,264
10,933
12,905
Net Interest Income
63,413
63,413
47,653
41,481
26,343
EBIT
1,044,994
1,044,994
884,967
757,326
708,766
EBITDA
1,108,987
1,108,987
963,056
833,681
781,755
Reconciled Cost of Revenue
725,133
725,133
668,437
576,738
517,324
Reconciled Depreciation
63,993
63,993
78,089
76,355
72,989
Net Income from Continuing Operation Net Minority Interest
910,458
910,458
784,534
682,907
590,172
Total Unusual Items Excluding Goodwill
8,430
8,430
11,750
-1,218
-1,990
Total Unusual Items
8,430
8,430
11,750
-1,218
-1,990
Normalized EBITDA
1,100,557
1,100,557
951,306
834,899
783,745
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
848.962
848.962
1,049.551
-102.312
-310.440
12/31/2021 - 12/19/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
3933.HK The United Laboratories International Holdings Limited
13.000
-1.37%
4523.T Eisai Co., Ltd.
4,050.00
+0.80%
0239.HK PAK FAH YEOW
2.350
+2.17%
1513.HK LIVZON PHARMA
26.150
+1.75%
2633.HK Jacobson Pharma Corporation Limited
1.200
-0.83%
0867.HK CMS
8.380
-1.76%
3692.HK Hansoh Pharmaceutical Group Company Limited
23.650
0.00%
CTX.TO Crescita Therapeutics Inc.
0.5600
0.00%
6896.HK Golden Throat Holdings Group Company Limited
4.730
-1.66%
0512.HK GRAND PHARMA
7.560
+6.33%